Jiangsu Lanfeng Bio-chemical Co.,Ltd (SHE:002513)
China · Delayed Price · Currency is CNY 4.350
+0.050 (1.16%)
Nov 10, 2026, 11:25 AM CST
SHE:002513 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 599.28 | 895.39 | 408.13 | 457.34 | 24 | 84.57 |
Cash & Short-Term Investments | 599.28 | 895.39 | 408.13 | 457.34 | 24 | 84.57 |
Cash Growth | -46.22% | 119.39% | -10.76% | 1805.42% | -71.62% | -74.49% |
Accounts Receivable | 705.68 | 808.32 | 432.97 | 532.28 | 97.86 | 78.67 |
Other Receivables | 56.94 | 62.7 | 113.7 | 207.84 | 77.23 | 187.04 |
Receivables | 762.62 | 871.01 | 546.67 | 740.12 | 182.4 | 272.79 |
Inventory | 319.78 | 297.07 | 182.44 | 167.77 | 98.05 | 132.7 |
Prepaid Expenses | - | - | - | - | 0.88 | - |
Other Current Assets | 293.89 | 233.35 | 170.31 | 210.44 | 54.94 | 55.98 |
Total Current Assets | 1,976 | 2,297 | 1,308 | 1,576 | 360.27 | 546.04 |
Property, Plant & Equipment | 1,654 | 1,785 | 1,754 | 1,526 | 868.19 | 935.6 |
Long-Term Investments | 0.2 | 12.43 | 9.1 | 8.89 | 7.44 | 4.89 |
Other Intangible Assets | 60.63 | 62.51 | 61.74 | 58.58 | 43.59 | 46.86 |
Long-Term Deferred Tax Assets | 256.7 | 224.67 | 205.82 | 126.77 | 96.52 | 170.16 |
Long-Term Deferred Charges | 13.46 | 15.34 | 0.81 | 0.53 | 0 | 0.02 |
Other Long-Term Assets | 18.17 | 79.78 | 79.71 | 90.84 | 95.21 | 20.31 |
Total Assets | 3,979 | 4,477 | 3,419 | 3,400 | 1,476 | 1,728 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 1,479 | 2,004 | 1,334 | 1,213 | 543.16 | 631.68 |
Accrued Expenses | 16.8 | 31.15 | 29.93 | 30.83 | 34.24 | 23.52 |
Short-Term Debt | 102.61 | 113.57 | 169.15 | 212.64 | 117.7 | 97.02 |
Current Portion of Long-Term Debt | - | 78.92 | 33.77 | - | - | - |
Current Portion of Leases | - | 3.49 | 0.89 | 0.67 | 0.57 | 0.33 |
Current Income Taxes Payable | 9.43 | 1.2 | 0.9 | 19.78 | 0.25 | 0.24 |
Current Unearned Revenue | 220.16 | 88.78 | 143.61 | 126.28 | 52.4 | 57.86 |
Other Current Liabilities | 1,318 | 985.24 | 620.37 | 914.37 | 288.6 | 234.59 |
Total Current Liabilities | 3,147 | 3,307 | 2,333 | 2,517 | 1,037 | 1,045 |
Long-Term Debt | 279.24 | 344.06 | 422.64 | 408.46 | - | - |
Long-Term Leases | 1.09 | 26.74 | 9.93 | 0.47 | 0.13 | 0.29 |
Long-Term Unearned Revenue | 205.33 | 217.87 | 208.23 | 114.11 | 6.16 | 8.96 |
Long-Term Deferred Tax Liabilities | - | 3.01 | 2.17 | 2.12 | 2.21 | 2.62 |
Other Long-Term Liabilities | 111.89 | 223.65 | 130.21 | 106.3 | 72.54 | 4.21 |
Total Liabilities | 3,744 | 4,122 | 3,106 | 3,149 | 1,118 | 1,061 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 375.59 | 375.59 | 375.28 | 373.94 | 373.94 | 340.09 |
Additional Paid-In Capital | 2,371 | 2,339 | 2,136 | 1,898 | 1,902 | 1,825 |
Retained Earnings | -2,699 | -2,594 | -2,403 | -2,151 | -1,819 | -1,498 |
Treasury Stock | -69.87 | -80.74 | -78.75 | -101.55 | -101.55 | - |
Comprehensive Income & Other | 3.8 | 3.64 | 3.26 | 5.48 | 1.74 | -0.25 |
Total Common Equity | -18.32 | 43.69 | 32.54 | 25.22 | 357.59 | 666.64 |
Minority Interest | 252.67 | 311.32 | 280.04 | 225.43 | -0 | - |
Shareholders' Equity | 234.35 | 355.01 | 312.58 | 250.66 | 357.59 | 666.64 |
Total Liabilities & Equity | 3,979 | 4,477 | 3,419 | 3,400 | 1,476 | 1,728 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 382.94 | 566.78 | 636.37 | 622.24 | 118.4 | 97.64 |
Net Cash (Debt) | 216.35 | 328.61 | -228.23 | -164.9 | -94.4 | -13.07 |
Net Cash Growth | -46.03% | - | - | - | - | - |
Net Cash Per Share | 0.58 | 0.88 | -0.62 | -0.44 | -0.25 | -0.04 |
Filing Date Shares Outstanding | 375.59 | 375.59 | 375.28 | 373.94 | 372.3 | 340.09 |
Total Common Shares Outstanding | 375.59 | 375.59 | 375.28 | 373.94 | 372.3 | 340.09 |
Working Capital | -1,171 | -1,010 | -1,026 | -941.8 | -676.64 | -499.2 |
Book Value Per Share | -0.05 | 0.12 | 0.09 | 0.07 | 0.96 | 1.96 |
Tangible Book Value | -78.95 | -18.82 | -29.2 | -33.35 | 314 | 619.78 |
Tangible Book Value Per Share | -0.21 | -0.05 | -0.08 | -0.09 | 0.84 | 1.82 |
Buildings | - | 1,139 | 1,278 | 866.63 | 667.45 | 686.42 |
Machinery | - | 1,687 | 1,395 | 938.68 | 1,295 | 1,458 |
Construction In Progress | - | 2.79 | 5.29 | 542.38 | 14.01 | 5.05 |